NTT DATA Focus

Discover our group initiatives

ServiceNow in Action: Revolutionizing Medical Device Management and Pharma Lifecycle Implementations

The NTT DATA Life Science Forum 2024: ServiceNow Hour highlighted the integration of ServiceNow into the life sciences industry. The event underlined ServiceNow's capabilities in automating workflows and ensuring regulatory compliance, particularly in Japan, and its expertise in enterprise medical device management in the North America pharmaceutical sector.

October 11, 2024
United States

Life Sciences

Data fabric for the pharmaceutical industry: a game changer

Data integrity and management play a vital role in life sciences. NTT DATA's GxP Data Fabric is a pivotal solution for managing data to improve usability, security, auditability and compliance. Watch a webinar by Ruud Nieuweboer, Global Head of Life Sciences at NTT DATA Business Solutions, to learn more about using this specialized cross-system platform as a tool for advanced analytics, AI and collaboration within and outside organizations.

October 9, 2024
Global

Life Sciences

Navigating the Pharma Data Revolution

In this webinar, Phil Rust, Lead Enterprise Architect, Healthcare at NTT DATA UK and Harsh Gandhi, Chief Information and Digital Officer at AstraZeneca Japan discuss the key technical, operational and strategic benefits of RWE implementation and process optimization. Phil and Harsh delve into the role of system integrators, future trends for both technology and industry stakeholders, and the challenges and opportunities that face the industry.

June 28, 2024
Global

Life Sciences

Digitally Transforming Life Science at DIA Europe

NTT DATA attended DIA Europe 2024, one of the largest international conferences for both professionals and stakeholders in the pharmaceutical and medical device industries.

June 25, 2024
Global

Life Sciences

The National Cancer Center Hospital, Japan: Cutting-edge Drug Discovery in the Modality-Driven Era

Japan, as a world leader in patent competitiveness and advanced technologies for cancer treatment, is in the process of developing a reliable strategy for drug discovery. This strategy will cover the whole process, from the creation of promising techniques to the successful development of new drugs.

March 22, 2024
Global

Life Sciences

Support for Assessing Therapeutic Efficacy in Patients with Inflammatory Bowel Disease through Unstructured Data in Electronic Health Records

At NTT DATA, we recently worked with Ono Pharmaceutical Co., Ltd. on a research study analyzing unstructured electronic health records (EHRs) data from patients with inflammatory bowel disease (IBD). The study aimed to identify the characteristics of IBD patients who exhibit resistance to medications, understand real-world treatment situations, and ultimately improve care. The aim of this project is to perform morphological analysis on electronic health records texts and have text mining processes to extract keywords characteristic of treatment-resistant patients. Rather than conducting extensive analyses such as building AI models, the focus will be on these text-based approaches.

March 1, 2024
Global

Life Sciences

Navigating the Pharma Data Revolution with AstraZeneca

Join our exclusive webinar with NTT DATA and AstraZeneca Japan healthcare technology executives for an expert discussion on RWE in commercial and medical fields, and the challenges — and benefits — of implementing effective patient and clinical big data analytics.

January 26, 2024
Global

Life Sciences

Streamlined Shipment Inspections at Otsuka Pharma

NTT DATA Introduces New System to Support the Pharmaceutical Product Shipment Inspection Process at Six Otsuka Pharmaceutical Domestic Factories

October 25, 2023
Japan

Life Sciences

Search and Extract data from RWE medical papers with Almirall

This project focused on constructing an NLP-based solution that allows researchers to extract information from RWE medical papers in different formats in which they tested the effect of an active principle in patients with atopic dermatitis.

June 26, 2023
Global

Life Sciences Data & Intelligence

Four Steps to a Digitally Enabled Post-COVID Life Sciences Enterprise

June 2, 2022
United States

Life Sciences Innovation

Three Realities That Every Life Sciences Enterprise Must Face in their Post-Pandemic Digital Transformation

April 29, 2022
United States

Life Sciences Innovation